Takeda in $145-Million Deal for Cancer Drug
By

By
Takeda Pharmaceutical has signed an exclusive licensing agreement with Exelixis, a South San Francisco, California-based biopharmaceutical company, for the commercialization and further clinical development in Japan of cabozantinib, Exelixis’ lead…

J&J to Acquire Actelion in $30-Billion Deal and Plans R&D Spin-Out
By

By
Johnson & Johnson (J&J) has agreed to acquire Actelion, an Allschwil, Switzerland-based biopharmaceutical company, in a deal valued at $30 billion and will spin out Actelion’s research and development unit…

Endo Restructures Corporate and Brand Pharma R&D Functions
By

By
Endo International has initiated a restructuring program that primarily impacts the company’s corporate functions and branded pharmaceutical research and development (R&D) functions in Malvern, Pennsylvania and Chestnut Ridge, New York as…

Celgene to Acquire Autoimmune Drug Company in $775-Million Deal
By

By
Celgene, a Summit, New Jersey-based biopharmaceutical company, has agreed to acquire Delinia, a privately held biotechnology company headquartered in San Francisco that develops therapeutics for autoimmune diseases, in a deal…

MilliporeSigma Launches Genotoxicity Screening
By

By
MilliporeSigma has launched a new genotoxicity screening service called CAN MultiFlow to predict genotoxic and mode-of-action properties of substances, ingredients, and drug compounds. The new service is offered through MilliporeSigma’s…

Amatsigroup Acquires Sterile-Injectable-Drug Manufacturer
By

By
Amatsigroup, a Fontenilles, France-headquarterd contract development and manufacturing organization, has acquired Disposable-Lab, a Martillac, France-based company that specializes in manufacturing sterile clinical batches of drug product in injectable forms. Amatsigroup’s…

Angus, Azelis Sign Nitroalkanes Distribution Deal
By

By
Azelis, an Antwerp, Belgium-headquartered specialty chemicals distributor, has entered two new distribution arrangements with Angus Chemical Company, a Buffalo Grove, Illinois-headquartered manufacturer and marketer of specialty and fine chemicals, for…

Abzena in $300-Million Deal for ADC Linker Technology
By

By
Abzena, a Cambridge, UK-headquartered services and technology provider for biopharmaceuticals, has signed a licensing agreement with an unnamed San Diego-based biopharmaceutical company for ThioBridge, Abzena’s proprietary antibody drug conjugate (ADC)…

Servier Signs MaSTherCell to Manufacture Cell Therapies
By

By
Servier, a pharmaceutical company headquartered in Neuilly-sur-Seine, France, has signed a master service agreement with Manufacturing Synergies for Therapeutic Cells (MaSTherCell), a Brussels, Belgium-based contract development and manufacturing organization, for…

Excipact Certifies VWR’s Chemical Manufacturing Sites
By

By
VWR, a Radnor, Pennsylvania-headquartered provider of laboratory products, services and solutions, has received EXCiPACT certifications at two of its chemical manufacturing sites, one in Aurora, Ohio and the other in…